FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Dirk Kuypers

Research Profile

Procedures

Chemicals & Drugs

Physiology

Concepts & Ideas

Genes & Molecular Sequences

Single Nucleotide Polymorphism

Disorders

Polyomavirus Infections

Co-author Network

Publications

TOP 3
H de Jonge; Dirk R J Kuypers
Response to "pretransplantation pharmacokinetic assessments to predict posttransplantation dosing requirements in renal transplant recipients: what is known?".
Dirk R J Kuypers; Patrick C Peeters; Jacques J Sennesael; Yves Vanrenterghem; Bernard Vrijens; Fabienne Dobbels; Nada Kanaan; Mireille N Kianda; Paulus Kristanto
Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring.
Maarten Naesens; Yves Vanrenterghem; B Meijers; Bert Bammens; Kathleen Claes; K De Vusser; Pieter Evenepoel; Dirk R J Kuypers; Evelyne Lerut
Chronic histological damage in early indication biopsies is an independent risk factor for late renal allograft failure.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Dirk Kuypers (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: H de Jonge; Dirk R J Kuypers
Response to "pretransplantation pharmacokinetic assessments to predict posttransplantation dosing requirements in renal transplant recipients: what is known?".
Clinical pharmacology and therapeutics 2013;93(4):307-8.
2013: Dirk R J Kuypers; Patrick C Peeters; Jacques J Sennesael; Yves Vanrenterghem; Bernard Vrijens; Fabienne Dobbels; Nada Kanaan; Mireille N Kianda; Paulus Kristanto
Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring.
Transplantation 2013;95(2):333-40.
2013: Maarten Naesens; Yves Vanrenterghem; B Meijers; Bert Bammens; Kathleen Claes; K De Vusser; Pieter Evenepoel; Dirk R J Kuypers; Evelyne Lerut
Chronic histological damage in early indication biopsies is an independent risk factor for late renal allograft failure.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2013;13(1):86-99.
2012: H de Jonge; Henriette de Loor; Yves Vanrenterghem; Kristin Verbeke; Dirk R J Kuypers
In vivo CYP3A4 activity, CYP3A5 genotype, and hematocrit predict tacrolimus dose requirements and clearance in renal transplant patients.
Clinical pharmacology and therapeutics 2012;92(3):366-75.
2012: Sam Heye; Geert Maleux; Raymond H Oyen; Kathleen Claes; Dirk R J Kuypers
Occupational radiation dose: percutaneous interventional procedures on hemodialysis arteriovenous fistulas and grafts.
Radiology 2012;264(1):278-84.
2012: Dirk R J Kuypers
Management of polyomavirus-associated nephropathy in renal transplant recipients.
Nature reviews. Nephrology 2012;8(7):390-402.
2012: Rachida Bouamar; Johannes W de Fijter; Dennis A Hesselink; Dirk R J Kuypers; Ilse P van der Heiden; Ron van Schaik; Willem Weimar; Teun van Gelder
Mycophenolic acid-related diarrhea is not associated with polymorphisms in SLCO1B nor with ABCB1 in renal transplant recipients.
Pharmacogenetics and genomics 2012;22(6):399-407.
2011: Brian J Nankivell; Dirk R J Kuypers
Diagnosis and prevention of chronic kidney allograft loss.
Lancet 2011;378(9800):1428-37.
2011: Henriette de Loor; Yves Vanrenterghem; Kristin Verbeke; Hylke de Jonge; Dirk R J Kuypers
A highly sensitive liquid chromatography tandem mass spectrometry method for simultaneous quantification of midazolam, 1'-hydroxymidazolam and 4-hydroxymidazolam in human plasma.
Biomedical chromatography : BMC 2011;25(10):1091-8.
2011: H de Jonge; Henriette de Loor; Yves Vanrenterghem; Kristin Verbeke; Dirk R J Kuypers
In vivo CYP3A activity is significantly lower in cyclosporine-treated as compared with tacrolimus-treated renal allograft recipients.
Clinical pharmacology and therapeutics 2011;90(3):414-22.
2011: Ben Sprangers; Dirk R J Kuypers; Yves Vanrenterghem
Immunosuppression: does one regimen fit all?
Transplantation 2011;92(3):251-61.
2011: Christoph Metalidis; Evelyne Lerut; Maarten Naesens; Dirk R J Kuypers
Expression of CYP3A5 and P-glycoprotein in renal allografts with histological signs of calcineurin inhibitor nephrotoxicity.
Transplantation 2011;91(10):1098-102.
2011: Christoph Metalidis; Dirk R J Kuypers
Emerging immunosuppressive drugs in kidney transplantation.
Current clinical pharmacology 2011;6(2):130-6.
2011: Marcelo Cantarovich; Nigel W Brown; Mary H H Ensom; Ashok Jain; Dirk R J Kuypers; Teun Van Gelder; J Michael Tredger
Mycophenolate monitoring in liver, thoracic, pancreas, and small bowel transplantation: a consensus report.
Transplantation reviews (Orlando, Fla.) 2011;25(2):65-77.
2011: Burkhard Tönshoff; Elias David-Neto; Robert Ettenger; Guido Filler; Teun van Gelder; Jens Goebel; Dirk R J Kuypers; Eileen Tsai; Alexander A Vinks; Lutz T Weber; Lothar Bernd Zimmerhackl
Pediatric aspects of therapeutic drug monitoring of mycophenolic acid in renal transplantation.
Transplantation reviews (Orlando, Fla.) 2011;25(2):78-89.
2011: Maarten Naesens; Minnie M Sarwal; Dirk R J Kuypers
Organ transplantation after cardiac death.
Lancet 2011;377(9761):203; author reply 204-5.
2010: Dirk R J Kuypers; Hylke de Jonge; Maarten Naesens; Yves Vanrenterghem
A prospective, open-label, observational clinical cohort study of the association between delayed renal allograft function, tacrolimus exposure, and CYP3A5 genotype in adult recipients.
Clinical therapeutics 2010;32(12):2012-23.
2010: Sylvie E M Vermeire; Hylke de Jonge; Katrien Lagrou; Dirk R J Kuypers
Cutaneous phaeohyphomycosis in renal allograft recipients: report of 2 cases and review of the literature.
Diagnostic microbiology and infectious disease 2010;68(2):177-80.
2010: Dirk R J Kuypers; Maarten Naesens; Hylke de Jonge; Evelyne Lerut; Kristin Verbeke; Yves Vanrenterghem
Tacrolimus dose requirements and CYP3A5 genotype and the development of calcineurin inhibitor-associated nephrotoxicity in renal allograft recipients.
Therapeutic drug monitoring 2010;32(4):394-404.
2010: Dirk R J Kuypers; Bert Bammens; Kathleen Claes; Pieter Evenepoel; Yves Vanrenterghem
Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: the need for true drug exposure measurements.
Transplantation 2010;89(10):1296-7; author reply 1297-8.
2010: Dirk R J Kuypers; Yannick Le Meur; Marcelo Cantarovich; Michael J Tredger; Susan E Tett; Dario Cattaneo; Burkhard Tönshoff; David Holt; Jeremy Chapman; Teun van Gelder
Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation.
Clinical journal of the American Society of Nephrology : CJASN 2010;5(2):341-58.
2009: Maarten Naesens; Evelyne Lerut; Hylke de Jonge; Boudewijn Van Damme; Yves Vanrenterghem; Dirk R J Kuypers
Donor age and renal P-glycoprotein expression associate with chronic histological damage in renal allografts.
Journal of the American Society of Nephrology : JASN 2009;20(11):2468-80.
2009: Maarten Naesens; Evelyne Lerut; Minnie M Sarwal; Boudewijn Van Damme; Yves Vanrenterghem; Dirk R J Kuypers
Balancing efficacy and toxicity of kidney transplant immunosuppression.
Transplantation proceedings 2009;41(8):3393-5.
2009: Hylke de Jonge; Maarten Naesens; Dirk R J Kuypers
New insights into the pharmacokinetics and pharmacodynamics of the calcineurin inhibitors and mycophenolic acid: possible consequences for therapeutic drug monitoring in solid organ transplantation.
Therapeutic drug monitoring 2009;31(4):416-35.
2009: Josep M Grinyó; Henrik Ekberg; Richard D Mamelok; Federico Oppenheimer; Jaime Sánchez-Plumed; Miguel Angel Gentil; Domingo Hernandez; Dirk R J Kuypers; Mercé Brunet
The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2009;24(7):2269-76.
2009: Maarten Naesens; Dirk R J Kuypers; Minnie Sarwal
Calcineurin inhibitor nephrotoxicity.
Clinical journal of the American Society of Nephrology : CJASN 2009;4(2):481-508.
2009: Dirk R J Kuypers; Bert Bammens; Kathleen Claes; Pieter Evenepoel; Evelyne Lerut; Yves Vanrenterghem
A single-centre study of adjuvant cidofovir therapy for BK virus interstitial nephritis (BKVIN) in renal allograft recipients.
The Journal of antimicrobial chemotherapy 2009;63(2):417-9.
2009: Dirk R J Kuypers
Immunotherapy in elderly transplant recipients: a guide to clinically significant drug interactions.
Drugs & aging 2009;26(9):715-37.
2009: Dirk R J Kuypers; Henrik Ekberg; Josep Grinyó; Björn Nashan; Flavio Vincenti; Paul Snell; Richard D Mamelok; Rene M Bouw
Mycophenolic acid exposure after administration of mycophenolate mofetil in the presence and absence of cyclosporin in renal transplant recipients.
Clinical pharmacokinetics 2009;48(5):329-41.
2008: L Kubasiewicz; G Maleux; Raymond Oyen; Yves Vanrenterghem; Dirk R J Kuypers
Pseudoaneurysm complicating protocol renal transplant biopsies: case reports.
Transplantation proceedings 2008;40(5):1397-8.
2008: Dirk R J Kuypers; Kathleen Claes; Bert Bammens; Pieter Evenepoel; Yves Vanrenterghem
Early clinical assessment of glucose metabolism in renal allograft recipients: diagnosis and prediction of post-transplant diabetes mellitus (PTDM).
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(6):2033-42.
2008: Dirk R J Kuypers
Immunosuppressive drug therapy and subclinical acute renal allograft rejection: impact and effect.
Transplantation 2008;85(7 Suppl):S25-30.
2008: Dirk R J Kuypers; Hylke de Jonge; Maarten Naesens; Henriette de Loor; Evelyne Halewijck; Marc Dekens; Yves Vanrenterghem
Current target ranges of mycophenolic acid exposure and drug-related adverse events: a 5-year, open-label, prospective, clinical follow-up study in renal allograft recipients.
Clinical therapeutics 2008;30(4):673-83.
2008: Dennis A Hesselink; Ron van Schaik; Madelon van Agteren; Johannes W de Fijter; Anders Hartmann; Martin Zeier; Klemens Budde; Dirk R J Kuypers; Przemyslav Pisarski; Yann Le Meur; Richard D Mamelok; Teun van Gelder
CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients.
Pharmacogenetics and genomics 2008;18(4):339-48.
2008: Henriette de Loor; Maarten Naesens; Kristin Verbeke; Yves Vanrenterghem; Dirk R J Kuypers
Stability of mycophenolic acid and glucuronide metabolites in human plasma and the impact of deproteinization methodology.
Clinica chimica acta; international journal of clinical chemistry 2008;389(1-2):87-92.
2008: Hylke de Jonge; Dirk R J Kuypers
Pharmacogenetics in solid organ transplantation: current status and future directions.
Transplantation reviews (Orlando, Fla.) 2008;22(1):6-20.
2008: Ben Sprangers; S Smets; Xavier Sagaert; A Wozniak; E Wollants; Marc Van Ranst; Maria Debiec-Rychter; Raf Sciot; Yves Vanrenterghem; Dirk R J Kuypers
Posttransplant Epstein-Barr virus-associated myogenic tumors: case report and review of the literature.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2008;8(1):253-8.
2007: Dirk R J Kuypers; H de Jonge; Maarten Naesens; Evelyne Lerut; Kristin Verbeke; Yves Vanrenterghem
CYP3A5 and CYP3A4 but not MDR1 single-nucleotide polymorphisms determine long-term tacrolimus disposition and drug-related nephrotoxicity in renal recipients.
Clinical pharmacology and therapeutics 2007;82(6):711-25.
2007: Maarten Naesens; Evelyne Lerut; B V Damme; Yves Vanrenterghem; Dirk R J Kuypers
Tacrolimus exposure and evolution of renal allograft histology in the first year after transplantation.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007;7(9):2114-23.
2007: Maarten Naesens; Henriette de Loor; Yves Vanrenterghem; Dirk R J Kuypers
The impact of renal allograft function on exposure and elimination of mycophenolic acid (MPA) and its metabolite MPA 7-O-glucuronide.
Transplantation 2007;84(3):362-73.
2007: Dirk R J Kuypers
Kidney transplantation: current issues and future prospects.
Acta clinica Belgica 2007;62(4):208-17.
2007: Evelyne Lerut; Maarten Naesens; Dirk R J Kuypers; Yves Vanrenterghem; Boudewijn Van Damme
Subclinical peritubular capillaritis at 3 months is associated with chronic rejection at 1 year.
Transplantation 2007;83(11):1416-22.
2007: Pieter Evenepoel; Kathleen Claes; Dirk R J Kuypers; Frans Debruyne; Yves Vanrenterghem
Parathyroidectomy after successful kidney transplantation: a single centre study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(6):1730-7.
2007: Evelyne Lerut; Dirk R J Kuypers; Erik Verbeken; Jack P M Cleutjens; Hans Vlaminck; Yves Vanrenterghem; Boudewijn Van Damme
Acute rejection in non-compliant renal allograft recipients: a distinct morphology.
Clinical transplantation 2007;21(3):344-51.
2007: Dirk R J Kuypers; Evelyne Lerut; Kathleen Claes; Pieter Evenepoel; Yves Vanrenterghem
Recurrence of light chain deposit disease after renal allograft transplantation: potential role of rituximab?
Transplant international : official journal of the European Society for Organ Transplantation 2007;20(4):381-5.
2006: Sven Smets; Raymond Oyen; Willy Coosemans; Dirk R J Kuypers
An unusual cause of ureteral obstruction in a renal allograft.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(12):3593-4.
2006: Maarten Naesens; Dirk R J Kuypers; Frank Streit; Victor W Armstrong; Michael Oellerich; Kristin Verbeke; Yves Vanrenterghem
Rifampin induces alterations in mycophenolic acid glucuronidation and elimination: implications for drug exposure in renal allograft recipients.
Clinical pharmacology and therapeutics 2006;80(5):509-21.
2006: Maarten Naesens; Dirk R J Kuypers; Kristin Verbeke; Yves Vanrenterghem
Multidrug resistance protein 2 genetic polymorphisms influence mycophenolic acid exposure in renal allograft recipients.
Transplantation 2006;82(8):1074-84.
2006: Dirk R J Kuypers
On the road towards strategic application of therapeutic drug monitoring of mycophenolic acid in renal allograft recipients.
Journal of postgraduate medicine 2006;52(4):243.
2006: Dirk R J Kuypers; Kathleen Claes; Pieter Evenepoel; Yves Vanrenterghem
Clinically relevant drug interaction between voriconazole and tacrolimus in a primary renal allograft recipient.
Transplantation 2006;81(12):1750-2.
2005: Vanessa Ooms; Marc Decupere; Evelyne Lerut; Yves Vanrenterghem; Dirk R J Kuypers
Secondary renal amyloidosis due to long-standing tubulointerstitial nephritis in a patient with Sjögren syndrome.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2005;46(5):e75-80.
2005: Evelyne Lerut; Dirk R J Kuypers; Boudewijn Van Damme
Polyomavirus interstitial nephritis and concurrent post-transplant lymphoma in a renal allograft: coincidence or more?
Transplant international : official journal of the European Society for Organ Transplantation 2005;18(11):1304-7.
2005: Dirk R J Kuypers; Maarten Naesens; Severine Vermeire; Yves Vanrenterghem
The impact of uridine diphosphate-glucuronosyltransferase 1A9 (UGT1A9) gene promoter region single-nucleotide polymorphisms T-275A and C-2152T on early mycophenolic acid dose-interval exposure in de novo renal allograft recipients.
Clinical pharmacology and therapeutics 2005;78(4):351-61.
2005: Dirk R J Kuypers; Ann-Karolien Vandooren; Evelyne Lerut; Pieter Evenepoel; Kathleen Claes; Robert Snoeck; Lieve Naesens; Yves Vanrenterghem
Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;5(8):1997-2004.
2005: Jacques Malaise; Dirk R J Kuypers; Kathleen Claes; Pieter Evenepoel; B Maes; Willy Coosemans; J Pirenne; Yves Vanrenterghem; Dominique Van Ophem; Jean-Paul Squifflet
Immunosuppressive drugs after simultaneous pancreas-kidney transplantation.
Transplantation proceedings 2005;37(6):2840-2.
2005: Dirk R J Kuypers; Geert M Verleden; Maarten Naesens; Yves Vanrenterghem
Drug interaction between mycophenolate mofetil and rifampin: possible induction of uridine diphosphate-glucuronosyltransferase.
Clinical pharmacology and therapeutics 2005;78(1):81-8.
2005: Marc Decupere; Vanessa Ooms; Raymond Oyen; Dirk R J Kuypers; Kathleen Claes
Artifactual hypocalcaemia after intravenous administration of gadodiamide (Omniscan).
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20(7):1516-7.
2005: Dirk R J Kuypers; Jacques Malaise; Kathleen Claes; Pieter Evenepoel; Bart Maes; Willy Coosemans; Jacques Pirenne; Yves Vanrenterghem
Secondary effects of immunosuppressive drugs after simultaneous pancreas-kidney transplantation.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20 Suppl 2():ii33-9, ii62.
2005: Dirk R J Kuypers; Kathleen Claes; Pieter Evenepoel; Bart Maes; Stefaan J Vandecasteele; Yves Vanrenterghem; Boudewijn Van Damme; Koenraad Desmet
Drug interaction between itraconazole and sirolimus in a primary renal allograft recipient.
Transplantation 2005;79(6):737.
2005: Dirk R J Kuypers; Kathleen Claes; Pieter Evenepoel; Bart Maes; Yves Vanrenterghem
A simplified strategy for clinical management of late cytomegalovirus infection after oral ganciclovir prophylaxis in renal recipients.
The Journal of antimicrobial chemotherapy 2005;55(3):391-4.
2005: Dirk R J Kuypers
Immunosuppressive drug monitoring - what to use in clinical practice today to improve renal graft outcome.
Transplant international : official journal of the European Society for Organ Transplantation 2005;18(2):140-50.
2005: Dirk R J Kuypers
Benefit-risk assessment of sirolimus in renal transplantation.
Drug safety : an international journal of medical toxicology and drug experience 2005;28(2):153-81.
2005: Gert Meeus; Dirk R J Kuypers; Kathleen Claes; Pieter Evenepoel; Bart Maes; Yves Vanrenterghem
A prospective, randomized, double-blind crossover study on the use of 5% citrate lock versus 10% citrate lock in permanent hemodialysis catheters.
Blood purification 2005;23(2):101-5.
2004: Dirk R J Kuypers; Kathleen Claes; Pieter Evenepoel; Bart Maes; Yves Vanrenterghem
The rate of gastric emptying determines the timing but not the extent of oral tacrolimus absorption: simultaneous measurement of drug exposure and gastric emptying by carbon-14-octanoic acid breath test in stable renal allograft recipients.
Drug metabolism and disposition: the biological fate of chemicals 2004;32(12):1421-5.
2004: Dirk R J Kuypers; Yves Vanrenterghem
Time to reach tacrolimus maximum blood concentration,mean residence time, and acute renal allograft rejection: an open-label, prospective, pharmacokinetic study in adult recipients.
Clinical therapeutics 2004;26(11):1834-44.
2004: Dirk R J Kuypers; H H Neumayer; L Fritsche; K Budde; J L Rodicio; Yves Vanrenterghem
Calcium channel blockade and preservation of renal graft function in cyclosporine-treated recipients: a prospective randomized placebo-controlled 2-year study.
Transplantation 2004;78(8):1204-11.
2004: Dirk R J Kuypers; Kathleen Claes; Pieter Evenepoel; Bart Maes; Yves Vanrenterghem
A prospective proof of concept study of the efficacy of tacrolimus ointment on uraemic pruritus (UP) in patients on chronic dialysis therapy.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19(7):1895-901.
2004: Dirk R J Kuypers; Kathleen Claes; Pieter Evenepoel; Bart Maes; Yves Vanrenterghem
Clinical efficacy and toxicity profile of tacrolimus and mycophenolic acid in relation to combined long-term pharmacokinetics in de novo renal allograft recipients.
Clinical pharmacology and therapeutics 2004;75(5):434-47.
2004: Dirk R J Kuypers; Yves Vanrenterghem
Monoclonal antibodies in renal transplantation: old and new.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19(2):297-300.
2004: Dirk R J Kuypers; Kathleen Claes; Pieter Evenepoel; Bart Maes; Willy Coosemans; Jacques Pirenne; Yves Vanrenterghem
Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.
Clinical pharmacokinetics 2004;43(11):741-62.
2003: Dirk R J Kuypers; Yves Vanrenterghem; J P Squifflet; M Mourad; D Abramowicz; M Oellerich; V Armstrong; M Shipkova; J Daems
Twelve-month evaluation of the clinical pharmacokinetics of total and free mycophenolic acid and its glucuronide metabolites in renal allograft recipients on low dose tacrolimus in combination with mycophenolate mofetil.
Therapeutic drug monitoring 2003;25(5):609-22.
2003: Dirk R J Kuypers; Kathleen Claes; Pieter Evenepoel; Bart Maes; Willy Coosemans; Jacques Pirenne; Yves Vanrenterghem
Long-term changes in mycophenolic acid exposure in combination with tacrolimus and corticosteroids are dose dependent and not reflected by trough plasma concentration: a prospective study in 100 de novo renal allograft recipients.
Journal of clinical pharmacology 2003;43(8):866-80.
2003: Dirk R J Kuypers; Kathleen Claes; Pieter Evenepoel; B Maes; Yves Vanrenterghem
Long-term pharmacokinetic study of the novel combination of tacrolimus and sirolimus in de novo renal allograft recipients.
Therapeutic drug monitoring 2003;25(4):447-51.
2003: Dirk R J Kuypers; Evelyne Lerut; Pieter Evenepoel; Bart Maes; Yves Vanrenterghem; Boudewijn Van Damme
C3D deposition in peritubular capillaries indicates a variant of acute renal allograft rejection characterized by a worse clinical outcome.
Transplantation 2003;76(1):102-8.
2003: Dirk R J Kuypers; Pieter Evenepoel; Bart Maes; Willy Coosemans; Jacques Pirenne; Yves Vanrenterghem
The use of an anti-CD25 monoclonal antibody and mycophenolate mofetil enables the use of a low-dose tacrolimus and early withdrawal of steroids in renal transplant recipients.
Clinical transplantation 2003;17(3):234-41.
2003: Dirk R J Kuypers; A Herelixka; Yves Vanrenterghem
Clinical use of rapamycin in renal allograft recipients identifies its relevant toxicity profile and raises unsolved questions: a single-center experience.
Transplantation proceedings 2003;35(3 Suppl):138S-142S.
2002: Dirk R J Kuypers; Y C Vanrenterghem
Tailoring immunosuppressive therapy.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2002;17(12):2051-4.
2002: Dirk R J Kuypers; Pieter Evenepoel; Bart D Maes; Willy Coosemans; Jacques Pirenne; Yves Vanrenterghem
Role of immunosuppressive drugs in the development of tissue-invasive cytomegalovirus infection in renal transplant recipients.
Transplantation proceedings 2002;34(4):1164-70.
2002: Dirk R J Kuypers; Kathleen Claes
Intracerebral haemorrhage caused by cefazoline-induced hypoprothrombinaemia in a renal transplant recipient.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2002;17(3):532-3.
2001: Dirk R J Kuypers
Calcineurin-inhibitor(s): both for recipient and donor?
Transplantation 2001;72(11):1726-7.
1999: Dirk R J Kuypers; Yves Vanrenterghem
Prophylaxis of cytomegalovirus infection in renal transplantation: new data for an old problem.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14(10):2304-8.